Fisher WE - Search Results

1

Enhancing the Potency and Specificity of Engineered T Cells for Cancer Treatment.

Sukumaran S, Watanabe N, Bajgain P, Raja K, Mohammed S, Fisher WE, Brenner MK, Leen AM, Vera JF. Sukumaran S, et al. Among authors: fisher we. Cancer Discov. 2018 Aug;8(8):972-987. doi: 10.1158/2159-8290.CD-17-1298. Epub 2018 Jun 7. Cancer Discov. 2018. PMID: 29880586 Free PMC article.

2

Current update of cytokines in pancreatic cancer: pathogenic mechanisms, clinical indication, and therapeutic values.

Feurino LW, Fisher WE, Bharadwaj U, Yao Q, Chen C, Li M. Feurino LW, et al. Among authors: fisher we. Cancer Invest. 2006 Nov;24(7):696-703. doi: 10.1080/07357900600981398. Cancer Invest. 2006. PMID: 17118780 Review.

3

Mesothelin is a malignant factor and therapeutic vaccine target for pancreatic cancer.

Li M, Bharadwaj U, Zhang R, Zhang S, Mu H, Fisher WE, Brunicardi FC, Chen C, Yao Q. Li M, et al. Among authors: fisher we. Mol Cancer Ther. 2008 Feb;7(2):286-96. doi: 10.1158/1535-7163.MCT-07-0483. Mol Cancer Ther. 2008. PMID: 18281514 Free PMC article.

4

Somatostatin receptor-1 induces cell cycle arrest and inhibits tumor growth in pancreatic cancer.

Li M, Wang X, Li W, Li F, Yang H, Wang H, Brunicardi FC, Chen C, Yao Q, Fisher WE. Li M, et al. Among authors: fisher we. Cancer Sci. 2008 Nov;99(11):2218-23. doi: 10.1111/j.1349-7006.2008.00940.x. Epub 2008 Sep 22. Cancer Sci. 2008. PMID: 18823376 Free PMC article.

5

PDX-1: demonstration of oncogenic properties in pancreatic cancer.

Liu SH, Patel S, Gingras MC, Nemunaitis J, Zhou G, Chen C, Li M, Fisher W, Gibbs R, Brunicardi FC. Liu SH, et al. Cancer. 2011 Feb 15;117(4):723-33. doi: 10.1002/cncr.25629. Epub 2010 Sep 30. Cancer. 2011. PMID: 20886630 Free PMC article.

6

Engineered T cells for pancreatic cancer treatment.

Katari UL, Keirnan JM, Worth AC, Hodges SE, Leen AM, Fisher WE, Vera JF. Katari UL, et al. Among authors: fisher we. HPB (Oxford). 2011 Sep;13(9):643-50. doi: 10.1111/j.1477-2574.2011.00344.x. Epub 2011 Jul 20. HPB (Oxford). 2011. PMID: 21843265 Free PMC article.

7

Quality metrics in pancreatic surgery.

Mohammed S, Fisher WE. Mohammed S, et al. Among authors: fisher we. Surg Clin North Am. 2013 Jun;93(3):693-709. doi: 10.1016/j.suc.2013.02.004. Epub 2013 Apr 11. Surg Clin North Am. 2013. PMID: 23632153 Review.

8

An assessment of the necessity of transfusion during pancreatoduodenectomy.

Ross A, Mohammed S, Vanburen G, Silberfein EJ, Artinyan A, Hodges SE, Fisher WE. Ross A, et al. Among authors: fisher we. Surgery. 2013 Sep;154(3):504-11. doi: 10.1016/j.surg.2013.06.012. Surgery. 2013. PMID: 23972656

9

Treatment of bacteriobilia decreases wound infection rates after pancreaticoduodenectomy.

Mohammed S, Evans C, VanBuren G, Hodges SE, Silberfein E, Artinyan A, Mo Q, Issazadeh M, McElhany AL, Fisher WE. Mohammed S, et al. Among authors: fisher we. HPB (Oxford). 2014 Jun;16(6):592-8. doi: 10.1111/hpb.12170. Epub 2013 Aug 29. HPB (Oxford). 2014. PMID: 23992045 Free PMC article.

10

Kinetics of tumor destruction by chimeric antigen receptor-modified T cells.

Anurathapan U, Chan RC, Hindi HF, Mucharla R, Bajgain P, Hayes BC, Fisher WE, Heslop HE, Rooney CM, Brenner MK, Leen AM, Vera JF. Anurathapan U, et al. Among authors: fisher we. Mol Ther. 2014 Mar;22(3):623-633. doi: 10.1038/mt.2013.262. Epub 2013 Nov 28. Mol Ther. 2014. PMID: 24213558 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

192 results

Search Page